BlackBerry Ltd (BBRY) Looking for Partnerships in Enterprise Sales Force

BlackBerry Ltd (NASDAQ:BBRY) is now confident that the concerns regarding its viability is reducing. The company is focusing its strength on enterprise but does not want to invest in an enterprise sales-force, instead BlackBerry Ltd (NASDAQ:BBRY) is looking forward to a partnership with a company that already has that.

CNBC’s Jon Fortt recently interviewed John Chen, the CEO of BlackBerry Ltd (NASDAQ:BBRY), in which Mr. Chen discussed the investors’ reactions to the turnaround measures by the company and the characteristics he is looking for in an enterprise partner.

“They all are very interested in our strategy, in our technology, in where we want to go. I have now found out that most people are no longer concerned about our viability on the enterprise customer side. They like seeing what’s happening, I am very grateful for that because at the beginning of time there were all these talks. They believed that we’ll be around and they believed our value was there. We have extremely good up-tick,” Chen said.

Research in Motion Ltd. (BBRY)

Fortt said that Chen was in New York to talk to talk to the three most important pillars to BlackBerry Ltd (NASDAQ:BBRY) government, financial institutions and pharmaceuticals. He also revealed that BlackBerry Ltd (NASDAQ:BBRY) would be launching ‘Blackberry Passport’, which, according to him is an odd shaped phone, targeting specifically the security heavy areas in which people carry two phones.

“We will love to have a broad sales channel, you know the so called market reach. I will probably pick more towards the application solution side. I think there is behind the MDM our huge market of security obviously and behind the security market is a whole IOT market, the internet of things market and so if you have me choose, I will like to make sure that we are well positioned in the IOT secure market and then the customer acquisition is so that if you have a good enough product to sell, they will come,” Chen added.

Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!